Document:

EX-10.11

 Exhibit 10.11 

[***] Certain information in this document has been excluded pursuant to Regulation S-K, Item 601(b)(10). Such excluded information is not material and
would likely cause competitive harm to the registrant if publicly disclosed. 
 Development Agreement 

This Development Agreement (“Agreement”), is made and entered into, to be effective as of January 29, 2020 (the “Effective Date”), by
and between LENSAR, Inc, a Delaware corporation having its principal place of business at 2800 Discovery Drive, Suite 100, Orlando, FL 32826 (“LENSAR”), and Oertli Instrumente AG, a Swiss corporation having a principal place of business at
Hafnerwisenstrasse 4, 9442 Berneck, Switzerland (“Oertli”). LENSAR and Oertli may each be referred to individually as a “Party” and collectively as the “Parties.” 

RECITALS: 

WHEREAS, LENSAR develops, manufactures, markets and commercializes certain femtosecond laser cataract surgery devices and related
supplies and services used for addressing cataract disease and other ophthalmic conditions; 
 WHEREAS, Oertli develops,
manufactures, markets and commercializes certain phacoemulsification devices, instruments and consumables that the Parties believe may be commercially useful when combined with a femtosecond laser cataract surgery device; 

WHEREAS, pursuant to the terms of this Agreement, the Parties wish to collaborate in the development of a combined femtosecond laser
– phacoemulsification device for use in ophthalmic surgery methods; 
 NOW, THEREFORE, in consideration of the mutual
agreements, covenants, terms and conditions herein contained, the Parties agree as follows: 
 Article 1 

Definitions 
 Section
1.1 Affiliate “Affiliate” means, with respect to a specified person (natural or juridical), a person that directly, or indirectly through one or more intermediaries, controls, or is controlled by, or is under common
control with, the person specified. “Control” means ownership of more than fifty percent (50%) of the shares of stock entitled to vote for the election of directors in the case of a corporation, and more than fifty percent (50%) of the
voting power in the case of a business entity other than a corporation. 
 Section 1.2 Combined Device. “Combined
Device” means a single device comprising both a femtosecond laser capability and a phacoemulsification capability which is developed pursuant to the Development Project. 

Section 1.3 Development Project. “Development Project” means the combined engineering and technical efforts of
LENSAR and Oertli for the development of the Combined Device. The Development Project is as substantially outlined in Exhibit A, or as modified pursuant to the mutual agreement of the Parties through the Term. 

Section 1.4 Intellectual Property Rights. “Intellectual Property Rights” means any inventions, discoveries,
improvements and ideas (whether or not they are in writing or reduced to practice) and works of authorship (whether or not they can be patented or copyrighted) that 

 
either Party makes, authors, or conceives (either alone or with others) during the course of and pursuant to the Development Project and related to the Combined Device, and any related filing of
a patent and/or patent application including any and all U.S., European and international patents issuing therefrom or claiming priority thereto and any and all continuations,
continuations-in-part, divisionals, extensions, supplementary protection certificates, reissues or reexaminations, or equivalent rights, which are based thereon or
claiming priority thereto, and any and all know-how, technology, data, reports, experiments or any other intellectual property rights. 

Article 2 
 Development
Project 
 Section 2.1 General. The Parties agree to commit the necessary resources and
personnel to successfully and collaboratively pursue the Development Project and to use commercially reasonable efforts to complete in a satisfactory manner the key deliverables ascribed to each Party. Each Party agrees to perform all of its
obligations hereunder using commercially reasonable efforts and with professionalism in accordance with standards prevalent in the industry. The Parties anticipate that the Development Project, which is attached hereto as Exhibit A, may be further
modified by the Parties during discussions throughout the Term, and in particular prior to initiating substantial engineering efforts, as may be agreed to between the Parties. 

Section 2.2 Management. If at any time either Party desires a change in the Development Project, the Parties shall discuss
the same in good faith. Upon agreement of the Parties to such change, the Parties will prepare a written amendment to Exhibit A memorializing such change. 

Section 2.3 Meetings and Reports. The Parties shall meet at a site designated by mutual agreement or by
teleconference every month (or more or less frequently upon mutual agreement), to discuss the progress of and all aspects of the Development Project. 

Article 3 
 Proprietary
Rights; Research License 
 Section 3.1 Proprietary Rights. Each Party shall remain the owner of
any Intellectual Property Rights owned by it as of the Effective Date. With respect to Intellectual Property Rights invented during the course of the Agreement, the inventor thereof shall be the owner, without regard to the other Party. Where the
Intellectual Property Rights are jointly made due to inventive contributions from both Oertli and LENSAR (or Affiliates thereof), as determined by applicable patent law, the Parties shall be joint and several owners and shall be entitled to practice
such Intellectual Property Rights in their sole discretion, and without regard to the other Party. 
 Section 3.2 Research
License. Each Party grants to the other a non-exclusive, royalty free, fully paid, non-transferable, non-sublicensable license under such Party’s Intellectual Property Rights, solely for research purposes with respect to the Development
Project. Neither Party shall have any rights to develop, commercialize or otherwise exploit any Intellectual 

  
 2 

 
Property Rights of the other Party in any manner, except as provided for in this Section 3.2. The licenses granted hereunder shall lapse upon termination of the Agreement or the expiration
of the Term. 
 Article 4 

Fees 

Section 4.1 Oertli Fees. In consideration for its efforts in accordance with this Agreement, LENSAR
agrees to pay to Oertli fees based on an hourly rate for actual time spent on the Development Project, comprising [***]. In addition, LENSAR agrees to pay incidental costs of travel, travel time up to 11 hours maximum per day and materials used
during the Development Project. 
 Section 4.2 Payment Method. LENSAR will pay Oertli within 30 days
of receipt of an invoice detailing the hours spent, the tasks associated with such time, and incidental costs for travel and materials. Payment will be made as follows: 

Wire Transfer 
 [***] 

[***] 
 Article 5 

Confidentiality 

Section 5.1 Confidentiality. The terms of confidentiality provided in the Non-Disclosure Agreement dated May 4th,
2019, shall be incorporated in their entirety to this Agreement, except that such terms shall be effective through the Term hereof, and that confidential information disclosed to a recipient will be maintained in confidentiality as provided in the
Non-Disclosure Agreement for a period of 2 years after the expiration of the Term or termination of this Agreement. 
 Article 6 

Agreement to Negotiations for Entering Into A Supply Agreement 

Section 6.1 Supply Agreement Negotiations. It is the intent of the Parties that, if the Development Project is
successful, they will enter into negotiations towards a Supply Agreement wherein Oertli will supply to LENSAR phacoemulsification devices for incorporation into the LENSAR femtosecond laser device, as a Combined Device as well as phaco instruments
and single use consumables needed for the phacoemulsification device. Upon mutually satisfactory success, defined as substantially meeting each of the key deliverables agreed upon by the Parties and provided for in Exhibit A, either Party may elect
to commence negotiations towards an agreement for such supply by sending written notice to the other Party. After receiving notification thereof, each Party agrees to enter into exclusive and good faith negotiations for a period of [***] days
related to the supply of Oertli phacoemulsification devices for the purpose of allowing LENSAR to manufacture a Combined Device, wherein LENSAR would be the exclusive distributor of the developed Combined Device. Price, quantity and delivery
schedule 

  
 3 

 
shall be determined during such negotiation period and will be reduced to writing with such other terms and conditions as are customary and necessary in a supply agreement typical in the
industry. 
 Article 7 

Term and Termination 

Section 7.1 Term of Agreement. The term of this Agreement shall be for 24 months (“Term”),
unless earlier terminated in accordance with this Article 7 by either Party or by the Parties mutual agreement, or unless extended by the Parties through mutual written amendment to this Agreement. 

Section 7.2 Termination for Cause. Either Party may terminate this Agreement by delivering written notice thereof to
the other Party if the other Party breaches any of its material obligations, representations or warranties as set forth herein, provided that such breaching Party shall have received written notice of such breach from the other Party and has failed
to correct such breach within thirty (30) days after such notice. 
 Section 7.3 Termination for
Convenience. Either Party may terminate this Agreement in its sole discretion by providing the other Party with sixty days prior written notice. In case of termination by LENSAR, Oertli has the right to bill all cumulated expenses up to the
date of termination and LENSAR will cover such expenses. 
 Section 7.4 Effect of Termination. Upon
termination of this Agreement or the expiration of the Term without renewal, the licenses granted in Section 3 will lapse and the Parties shall have no further obligations to each other, except for those provided in Articles 5, 8, 9 and 11. 

Article 8 

Representations and Warranties 

Section 8.1 Representations and Warranties of Both Parties. Each Party represents and warrants that:
(a) it shall perform its obligations under this Agreement in a timely, competent and workmanlike manner as described in the Exhibit A; (b) it has full authority to enter into this Agreement and has completed such corporate formalities and
authorizations as are necessary for it to enter into this Agreement, and that the signatory is the authorized agent of such Party for the purposes of entering into this Agreement; (c) neither the execution nor delivery of this Agreement nor the
carrying on of the business contemplated hereby, nor the conduct of the Development Project as proposed, will conflict with or result in a breach of the terms, conditions or provisions of, or constitute a default under, any contract, covenant or
instrument under which such Party is now obligated. 
 Section 8.2 Anti-Corruption Warranties;
Debarment. Each Party agrees that that it shall not cause the other Party to be in violation of the Anti-Corruption Laws or otherwise cause any reputational harm to the other Party; that it shall fully cooperate with the other Party in
ensuring compliance with the Anti-Corruption Laws and all other Applicable Law; and that it shall promptly notify the other Party if it learns or has any information or suspicion that there 

  
 4 

 
may be a violation of the Anti-Corruption Laws in connection with the performance of this Agreement. Each Party further represents and warrants that it has not been debarred by any applicable
Regulatory Authority or other governmental entity, including under subsections 306(a) or (b) of the FDCA and will not use and has not used, to the best of its knowledge, in any capacity the services of any person who has been debarred by
any applicable Regulatory Authority. “Anti-Corruption Laws” as used herein means all applicable law dealing with bribery or corruption, including, to the extent applicable, the U.S. Foreign Corrupt Practices Act of 1977 (the
“FCPA”), the U.K. Bribery Act 2010, and any law implementing the OECD Convention on Combating Bribery of Foreign Public Officials in International Transactions. 

Article 9 
 Indemnity;
Limitation of Liability 
 Section 9.1 Indemnity. Each Party shall indemnify and hold the other
harmless from any and all third party claims, demands, losses, damages, suits, judgments, penalties and liabilities, of any kind and nature whatsoever, including payment of reasonable attorneys’ fees, of a third party based upon a material
breach of this Agreement by the other Party or upon any grossly negligent or wrongful act of such other Party which may arise, directly or indirectly, from or in connection with, their performance of the terms and conditions of this Agreement.

 Section 9.2 Limitation of Liability. IN NO EVENT SHALL EITHER PARTY’S AGGREGATE LIABILITY HEREUNDER,
BASED ON ANY THEORY OF LIABILITY OR CAUSE OF ACTION, EXCEED THE TOTAL AMOUNT OF FEES PAID BY LENSAR TO OERTLI UNDER THIS AGREEMENT. IN NO EVENT SHALL EITHER PARTY BE LIABLE FOR ANY INDIRECT, SPECIAL OR CONSEQUENTIAL DAMAGES, INCLUDING BUT NOT
LIMITED TO LOST PROFITS, SAVINGS OR REVENUE, EVEN IF ADVISED OF THE POSSIBILITY OF SUCH DAMAGES. 
 Article 10 

Further Assurances 
 If
either Party requires that this Agreement or any document relating to the subject matter hereof to be legalized and/or notarized, or submitted, filed or registered with any government agency, the other Party agrees to assist in complying with those
requirements. Any such submission, filing or registration shall be made in the name and for the benefit of a Party and shall be at the expense of such Party. 

Article 11 

Miscellaneous 

Section 11.1 Independent Contractor. The Parties are independent contractors of each other and
neither Party is entitled to privileges, services, facilities and benefits that are available to the other Party’s employees. 

Section 11.2 Entire Agreement. This Agreement, including all Exhibits specifically mentioned, constitutes the entire
understanding between the Parties relating to the subject matter of this Agreement, and supersedes all prior or contemporaneous discussions, representations, correspondence and agreements, oral or written, between the Parties not expressly embodied
herein. 

  
 5 

 Section 11.3 Amendments; Waiver. No amendments,
changes, extensions or modifications to this Agreement are valid and binding except if in writing and signed by the Parties. Waiver by either Party of a breach or violation of any provision of this Agreement shall not operate as, or be construed to
be, a waiver of any prior, concurrent or subsequent breach. None of the provisions of this Agreement are considered waived by either Party except when such waiver is given in writing. 

Section 11.4 Governing Law; Jurisdiction; Venue. This Agreement will be construed and interpreted under and in
accordance with the substantive laws of Switzerland, without regard to conflicts of law principles and to the provisions of the United Nations Convention on Contracts for the International Sale of Goods (CISG). Any action or proceeding arising under
or relating to this Agreement will be brought only in the courts of the Canton of St. Gallen, Switzerland, to which each Party consents to jurisdiction for the purposes of this Agreement only. 

Section 11.5 Notice. Any notices required in this Agreement shall be in writing, shall be delivered in
one of the following ways and deemed to have been received (a) on the date delivered if delivered by hand, (b) the next following business day after being sent if sent by overnight courier, or (c) three (3) business days after
mailing, postage prepaid, by certified mail, return receipt requested, to the Party as designated by the notices clause below. 

Section 11.6 Severability. In the event that any provision contained herein is held to be invalid or unenforceable, all
other provisions of this Agreement are deemed severable and will remain enforceable to the full extent permitted by law. 

Section 11.7 Counterparts; Facsimile Signatures. This Agreement may be executed in two counterparts,
each of which are deemed an original, but both of which together constitute one and the same instrument. Copies of signatures sent by facsimile or electronic mail transmission are deemed to be originals for purposes of execution and proof of this
Agreement. 
 Section 11.8 Successors and Assigns. This Agreement shall be binding upon and inure to the
benefit of the Parties hereto and the successors or permitted assigns of the Parties hereto. The rights and obligations of either Party herein may not be assigned, except that such rights and obligations may be assigned to any Affiliate of a Party
or to any successor of all or substantially all of the business or assets of a Party to which this Agreement relates. 

Section 11.9 Titles and Headings; Construction. Titles and headings to Sections herein are inserted
for the convenience of reference only and are not intended to be a part of or to affect the meaning or interpretation of this Agreement. This Agreement shall be construed without regard to any presumption or other rule requiring construction hereof
against the Party causing this Agreement to be drafted. 

  
 6 

 Section 11.10 Benefit. Nothing in this Agreement,
expressed or implied, is intended to confer on any person other than the Parties hereto or their respective successors or assigns, any rights, remedies, obligations or liabilities under or by reason of this Agreement. 

Section 11.11 Notices. All notices or other communications to a Party required or permitted hereunder shall be in writing
and shall be delivered personally or by facsimile (receipt confirmed electronically) to such Party (or, in the case of an entity, to an executive officer of such Party) or shall be sent by a reputable express delivery service or by certified mail,
postage prepaid with return receipt requested, addressed as follows: 
 If to LENSAR to: 

By Mail or Overnight Courier: 2800 Discovery Drive, Suite 100, Orlando, FL 32826. 

By Email: [***] and [***]. 
 If to
Oertli to: 
 By Mail or Overnight Courier: [***] 

By Email: [***] 
 Any Party may change the
above-specified recipient and/or mailing address by notice to the other Party given in the manner herein prescribed. All notices shall be deemed given on the day when actually delivered as provided above (if delivered personally or by facsimile,
provided that any such facsimile is received during regular business hours at the recipient’s location) or on the day shown on the return receipt (if delivered by mail or delivery service). 

IN WITNESS WHEREOF, the Parties have duly executed this Agreement as of the date set forth below and effective as of the Effective Date. 

 

			
	LENSAR, Inc.
	By:	 	 /s/ Nicholas T. Curtis

	Name:	 	 CEO Nicholas T. Curtis

	Title:	 	 CEO

	Date:	 	 January 29, 2020

  

			
	Oertli Instrumente, AG
	By:	 	 /s/Thomas Bosshard

	Name:	 	 Thomas Bosshard

	Title:	 	 Director Sales & Marketing

	Date:	 	 January 30, 2020

  
 7 

 EXHIBIT A 

Development Project Description 
 [***]

 [***] 
 [***] 

[***] 
 [***] 

[***] 
 [***] 

[***] 
 [***] 

[***] 

  
 8Exhibit

Exhibit 10.1

SUCCESS INCENTIVE PLAN
CASH SUCCESS UNIT AND STOCK SUCCESS UNIT AGREEMENT WITH EMPLOYEE 
(Unum Group Stock Incentive Plan of 2017)
THIS AGREEMENT (this “Agreement”), dated as of [Grant Date], is entered into by and between Unum Group, a Delaware corporation (the “Company”), and [Participant Name] (the “Employee”).
W I T N E S S E T H
In consideration of the mutual promises and covenants made herein and the mutual benefits to be derived herefrom, the parties hereto agree as follows:
		
	1.
	Grant, Vesting and Forfeiture of Cash Success Units and Stock Success Units.

(a)Grant.  Subject to the provisions of this Agreement and to the provisions of the Unum Group Stock Incentive Plan of 2017 (as the same may be amended, the “Plan”), the Company hereby grants to the Employee, as of [Grant Date] (the “Grant Date”):
(i)    [Number of CSUs] Cash Success Units (“CSUs”), each of which shall be deemed a Performance Unit under the Plan, representing a right to receive $1.00.
(ii)    [Number of SSUs] Stock Success Units (“SSUs”), each of which shall be deemed a Restricted Stock Unit under the Plan, representing a right to receive one Share.  
All capitalized terms used herein, to the extent not defined, shall have the meaning set forth in the Plan.
		
	(b)
	Earning CSUs and SSUs/Performance Periods.

(i)    Early Performance Vesting.  Subject to Section 1(c) below, (A) the Employee is eligible to earn one-third of the CSUs and one-third of the SSUs in accordance with Schedule A attached hereto on the date that the Committee certifies that the Company has achieved the performance goals for the First Performance Period set forth on Schedule A, which date shall be no later than two and a half months after the end of the first performance period extending from January 1, 2021 to December 31, 2021, inclusive (the “First Performance Period”), (B) the Employee is eligible to earn up to two-thirds of the CSUs (less any CSUs earned under clause (A) above) and up to two-thirds of the SSUs (less any SSUs earned under clause (A) above) in accordance with Schedule A on the date that the Committee certifies that the Company has achieved the performance goals for the Second Performance Period set forth on Schedule A, which date shall be no later than two and a half months after the end of the second performance period extending from January 1, 2021 to December 31, 2023, inclusive (the “Second Performance Period”), and (C) the Employee is eligible to earn up to 100% of the CSUs (less any CSUs earned under clauses (A) and (B) above) and up to 100% of the SSUs (less any SSUs earned under clauses (A) and (B) above) in accordance with Schedule A on the date that the Committee certifies that the Company has achieved the performance goals for the Third Performance Period set forth on Schedule A, which date shall be no later than two and a half months after the end of the third performance period extending from January 1, 2021 to December 31, 2025, inclusive (the “Third Performance Period” and together with the First Performance Period and Second Performance Period, the “Performance Periods”).  Subject to the terms and conditions of this Agreement, the CSUs and SSUs earned pursuant to Section 1(b)(i) shall vest and no longer be subject to any restriction upon the expiration of the applicable Performance Period. 
(ii)    Time-Based Vesting.  Notwithstanding Section 1(b)(i) or the level of achievement of the performance goals set forth on Schedule A, but subject to Section 1(c) below, any CSUs or SSUs that do not become earned in accordance with Section 1(b)(i) will become earned on the sixth anniversary of the Grant Date (the “Final Vesting Date”) and shall fully vest and no longer be subject to any restriction on such date.

1172165        
(US – 08/2020)

		
	(c)
	Forfeiture; Committed Shares.

(i)    Termination of Employment.  Except as otherwise provided in Section 6(b) below, upon the Employee’s Termination of Employment for any reason prior to the Final Vesting Date, all CSUs and SSUs still subject to restriction shall be forfeited.  For purposes of this Agreement, employment with the Company shall include employment with the Company’s Affiliates and successors.  Nothing in this Agreement or the Plan shall confer upon the Employee any right to continue in the employ of the Company or any of its Affiliates or interfere in any way with the right of the Company or any such Affiliates to terminate the Employee’s employment at any time.
(ii)    Sale of Committed Shares.  In connection with the grant of the SSUs, the Employee hereby commits to retain and not sell or otherwise transfer a number of Shares that are owned by the Employee as of the date hereof equal to the number of SSUs granted hereunder (the “Committed Shares”) until such date as the SSU associated with such Committed Share vests and is no longer subject to any restriction.  If the Employee sells or otherwise transfers any Committed Share prior to such date, each associated SSU still subject to restriction shall be forfeited.
		
	2.
	Settlement of CSUs and SSUs.

(a)    Subject to Section 9 (pertaining to the withholding of taxes), and except as otherwise provided in Section 6, (i) with respect to the CSUs that become earned in accordance with Section 1(b)(i), as soon as practicable after the date on which the applicable Performance Period during which the CSUs become earned expires and the Committee certifies that the Company has achieved the performance goals set forth on Schedule A, and in no event later than two and a half months after the end of such Performance Period, and (ii) with respect to CSUs which become earned in accordance with Section 1(b)(ii), as soon as practicable after the Final Vesting Date, and in no event later than two and a half months after the Final Vesting Date, in each case, the Company shall pay to the Employee a lump sum amount equal to $1.00 for each CSU earned pursuant to this Agreement.
(b)    Subject to Section 9 (pertaining to the withholding of taxes), and except as otherwise provided in Section 6, (i) with respect to the SSUs that become earned in accordance with Section 1(b)(i), as soon as practicable after the date on which the applicable Performance Period during which the SSUs become earned expires and the Committee certifies that the Company has achieved the performance goals set forth on Schedule A, and in no event later than two and a half months after the end of such Performance Period, and (ii) with respect to SSUs which become earned in accordance with Section 1(b)(ii), as soon as practicable after the Final Vesting Date, and in no event later than two and a half months after the Final Vesting Date, in each case, the Company shall deliver to the Employee, in book-position or certificate form, one Share that does not bear any restrictive legend making reference to this Agreement for each SSU earned pursuant to this Agreement. 
		
	3.
	Nontransferability of the CSUs and SSUs.

Until such time as the CSUs and SSUs are ultimately settled as provided in Section 2 above, the CSUs, cash payments covered by the CSUs, SSUs and Shares covered by the SSUs shall not be transferable by the Employee by means of sale, assignment, exchange, encumbrance, pledge, hedge or otherwise; provided, however, that nothing in this Section 3 shall prevent transfers by will or by the applicable laws of descent and distribution.  Any purported or attempted transfer of such CSUs, cash payments covered by the CSUs, SSUs, or Shares covered by the SSUs in contravention of this Section 3 shall be null and void.
		
	4.
	Rights as a Stockholder.

Until such time as the SSUs are ultimately settled as provided in Section 2 above, the Employee shall not be entitled to any rights of a stockholder with respect to the SSUs (including, without limitation, any voting rights); provided that with respect to any dividends paid on Shares underlying the SSUs, such dividends will be notionally accounted for and shall vest and be settled in cash at such time as, and in the same ratio and only to the extent that, the underlying SSUs vest and are settled.

1172165
2

		
	5.
	Confidentiality; Non-Competition; Non-Solicitation; Non-Disparagement.

(a)    The Employee acknowledges that during the course of employment or engagement with the Company and its Affiliates the Employee has received and will continue to have access and exposure to secret and proprietary information, including but not limited to information about the Company’s and its Affiliates’ business, business practices and processes, customers, and prospective customers, the value of which is derived in part from the fact that the information is not generally known to the public (“Confidential Information”).  The Employee acknowledges that the Company and its Affiliates have spent significant time, effort and resources protecting the Confidential Information and that the Confidential Information has contributed to customer goodwill and is of significant competitive value to the Company and its Affiliates in the businesses in which they compete, and that the use or disclosure, even if inadvertent, of the Confidential Information to or for the benefit of a competitor would cause significant damage to the legitimate business interests of the Company and its Affiliates.  Accordingly, in order to protect the legitimate business and customer goodwill interests of the Company and its Affiliates, to protect the Confidential Information against inappropriate use or disclosure, and in consideration of the grant of and the opportunity to earn the CSUs and SSUs in accordance with the provisions of this Agreement, the Employee hereby covenants and agrees to comply with the confidentiality, non-competition, non-solicitation and non-disparagement provisions set forth in this Section 5(a) (collectively, the “Award Restrictions”).  Except to the extent expressly provided otherwise below, the Employee agrees to comply with the Award Restrictions for the period commencing on the Grant Date and extending through the date that is 12 months following the Employee’s Termination of Employment for any reason (such period, the “Restricted Period”).
(i)    The Employee will use Confidential Information gained during employment or engagement with the Company or any Affiliate for the benefit of the Company only and, without the prior written consent of the Company, shall not, at any time during the Restricted Period or thereafter, directly or indirectly, divulge, reveal or communicate any Confidential Information to any person or entity whatsoever, or use any Confidential Information for the Employee’s own benefit or for the benefit of others, other than as required by law or legal process.  For purposes of the foregoing, Confidential Information shall not include information that was or is available to the Employee on a non-confidential basis from a source other than the Company or becomes generally available to the public, other than as a result of disclosure by the Employee.
(ii)    The Employee shall not, at any time during the Restricted Period, without the prior written consent of the Company, directly or indirectly, own, manage, operate, join, control, or participate in the ownership, management, operation or control of, or be employed by, consult with, render services for, or be connected in any other manner with, any Competing Business, whether for compensation or otherwise.  For the purposes of this Agreement, a “Competing Business” shall be any business in the United States which is engaged in the sale or provision of employee benefits or other products or services of the type offered by the Company or its Affiliates (including without limitation, life, critical illness, income protection, disability, accident, dental, vision, hospital indemnity insurance, leave management, and stop loss), unless the Employee’s primary duties and responsibilities with respect to such business are not related to the management, operation or provision of such products or services.  Notwithstanding the requirements of this paragraph, the Employee shall not be prohibited from owning less than 1% of any publicly traded corporation, whether or not such corporation is deemed to be a Competing Business.
(iii)    The Employee shall not, at any time during the Restricted Period, without the prior written consent of the Company, directly or indirectly, either for the Employee’s own benefit or purpose or for the benefit or purpose of any other person or entity, solicit, assist, or induce any Covered Employee to terminate his or her relationship with the Company or its Affiliates (regardless of who first initiates the communication), or help another person or entity evaluate any Covered Employee as an employment candidate or offer to employ, call on, or actively interfere with the Company’s or any Affiliate’s relationship with any Covered Employee, provided that this paragraph shall not prohibit general solicitations in the form of classified advertisements or the like in newspapers, on the internet, or in other media.  For purposes of this Agreement, “Covered Employee” means an individual who is an employee, representative, or officer of the Company or any Affiliate at the time of the solicitation, assistance, or inducement or as of the date of the Employee’s Termination of Employment.

1172165
3

(iv)    The Employee shall not, at any time during the Restricted Period, without the prior written consent of the Company, directly or indirectly, either for the Employee’s own benefit or purpose or for the benefit or purpose of any other person or entity, use any Confidential Information to solicit or accept any business from any customers of the Company or any Affiliate, or any broker with regard to customers of the Company or any Affiliate (regardless of who first initiates the communication), whom the Employee serviced, solicited or had contact with while employed or engaged by the Company or any Affiliate.
(v)    The Employee shall not, at any time during the Restricted Period, directly or indirectly, disparage or make any statement, oral or written, public or in private, which is reasonably foreseeable as harming the Company’s or any Affiliate’s business interests or impacts negatively on the Company’s or any Affiliate’s business reputation or reputation in the community.  Nothing in this paragraph will be construed to prevent the Employee from communicating with or responding to a request for information from a federal, state, administrative agency or court.
(b)    Any termination of the Employee’s employment or the termination or expiration of this Agreement shall have no effect on the continuing operation of this Section 5.
(c)    The terms and provisions of this Section 5 are intended to be separate and divisible provisions and if, for any reason, any one or more of them is held to be invalid or unenforceable, neither the validity nor the enforceability of any other provision of this Agreement shall thereby be affected.  The parties hereto acknowledge that the potential restrictions on the Employee’s future employment imposed by this Section 5 are reasonable in both duration and geographic scope and in all other respects.  If for any reason any court of competent jurisdiction shall find any provisions of this Section 5 unreasonable in duration or geographic scope or otherwise, the Employee and the Company agree that the restrictions and prohibitions contained herein shall be effective to the fullest extent allowed under applicable law in such jurisdiction.
(d)    The Employee acknowledges and agrees that any breach or threatened breach of the Award Restrictions will result in substantial, continuing and irreparable injury to the Company and/or its Affiliates.  Therefore, in addition to any other remedy that may be available to the Company and/or its Affiliates, the Company and/or its Affiliates shall be entitled to equitable and/or injunctive relief to prevent any breach or threatened breach of such provisions, and to specific performance of each of the terms thereof in addition to any other legal or equitable remedies that the Company or any Affiliate may have.  Without limiting the foregoing, if the Employee violates any Award Restrictions, then all of the Employee’s outstanding CSUs and SSUs hereunder shall immediately be forfeited.
		
	6.
	Adjustment; Change in Control.

(a)    In the event of certain transactions prior to the time the SSUs are ultimately settled as provided in Section 2 above, the SSUs shall be subject to adjustment as provided in Section 3(d) of the Plan or any applicable successor provision under the Plan.
(b)    Notwithstanding anything in Section 1 to the contrary, upon a Termination of Employment of the Employee occurring upon or during the two years immediately following the date of a Change in Control (but prior to the settlement of the CSUs and SSUs in accordance with Section 2 above) by reason of death or Disability, by the Company without Cause, or by the Employee for Good Reason (as defined in the Plan, except that if the Employee is covered by a separate written plan or agreement providing for payments upon a Termination of Employment for Good Reason upon or within two years following a Change in Control, then as defined in such plan or agreement), then the CSUs and SSUs shall become free of all restrictions and fully vested and shall be settled as soon as practicable following the date of Termination of Employment (but not later than 30 days thereafter); provided, however, in each case, that any CSUs or SSUs that constitute “nonqualified deferred compensation” as defined under Section 409A of the Code shall, to the extent necessary to avoid the imposition of penalty taxes under Section 409A of the Code, only be so settled if the Change in Control constitutes a “change in control event” within the meaning of Section 409A of the Code and shall otherwise only be settled on the earliest date permissible under Section 409A of the Code.

1172165
4

(c)    Nothing in this Section 6 shall preclude the Company from settling, upon a Change in Control, any CSUs or SSUs (to the extent effectuated in accordance with Treasury Reg. § 1.409A-3(j)(4)(ix)).
		
	7.
	Payment of Transfer Taxes, Fees and Other Expenses.

The Company agrees to pay any and all original issue taxes and stock transfer taxes that may be imposed on the issuance of Shares received by an Employee in connection with the SSUs, together with any and all other fees and expenses necessarily incurred by the Company in connection therewith.
		
	8.
	Other Restrictions.

(a)    The SSUs shall be subject to the requirement that, if at any time the Committee shall determine that (i) the listing, registration or qualification of the Shares subject or related thereto upon any securities exchange or under any applicable law is required, or (ii) the consent or approval of any government regulatory body is required, then in any such event, the grant of SSUs shall not be effective unless such listing, registration, qualification, consent or approval shall have been effected or obtained free of any conditions not acceptable to the Committee.
(b)    If the Employee is an insider as described under the Company’s Insider Trading Policy (as in effect from time to time and any successor policies), the Employee shall be required to obtain pre-clearance from the General Counsel or Securities Counsel of the Company prior to purchasing or selling any of the Company’s securities, including any Shares issued upon vesting of the SSUs, and may be prohibited from selling such securities other than during an open trading window.  The Employee further acknowledges that, in its discretion, the Company may prohibit the Employee from selling such securities even during an open trading window if the Company has concerns over the potential for insider trading.
		
	9.
	Taxes and Withholding.

No later than the date as of which an amount first becomes includible in the gross income of the Employee for federal, state, local or foreign income, employment or other tax purposes with respect to any CSUs or SSUs, the Employee shall pay to the Company, or make arrangements satisfactory to the Company regarding the payment of, federal, state, local and foreign taxes that are required by applicable laws and regulations to be withheld with respect to such amount.  The obligations of the Company under this Agreement shall be conditioned on compliance by the Employee with this Section 9, and the Company shall, to the extent permitted by law, have the unilateral right to deduct any such taxes from any payment otherwise due to the Employee, including deducting such amount from the delivery of Shares upon settlement of the SSUs and the delivery of cash upon settlement of the CSUs, in each case that gives rise to the withholding requirement.
		
	10.
	Notices.

All notices and other communications under this Agreement shall be in writing and shall be given by hand delivery to the other party or by facsimile, overnight courier, or registered or certified mail, return receipt requested, postage prepaid, addressed as follows:
If to the Employee:
At the most recent address on file at the Company
If to the Company:
Unum Group 
1 Fountain Square 
Chattanooga, Tennessee 37402 
Attention:  Executive Compensation, Human Resources

1172165
5

or to such other address or facsimile number as any party shall have furnished to the other in writing in accordance with this Section 10.  Notices and communications shall be effective when actually received by the addressee.  Notwithstanding the foregoing, the Employee consents to electronic delivery of documents required to be delivered by the Company under the securities laws.
		
	11.
	Effect of Agreement.

This Agreement is personal to the Employee and, without the prior written consent of the Company, shall not be assignable by the Employee otherwise than by will or the laws of descent and distribution.  This Agreement shall inure to the benefit of and be enforceable by the Employee’s legal representatives.  This Agreement shall inure to the benefit of and be binding upon the Company and its successors and assigns.
		
	12.
	Laws Applicable to Construction; Consent to Jurisdiction.

The interpretation, performance and enforcement of this Agreement shall be governed by the laws of the State of Delaware without reference to principles of conflict of laws, as applied to contracts executed in and performed wholly within the State of Delaware.  In addition to the terms and conditions set forth in this Agreement, the CSUs and SSUs are subject to the terms and conditions of the Plan, which is hereby incorporated by reference.
		
	13.
	Severability.

The invalidity or enforceability of any provision of this Agreement shall not affect the validity or enforceability of any other provision of this Agreement.
		
	14.
	Conflicts and Interpretation.

In the event of any conflict between this Agreement and the Plan, the Plan shall control.  In the event of any ambiguity in this Agreement, or any matters as to which this Agreement is silent, the Plan shall govern including, without limitation, the provisions thereof pursuant to which the Committee has the power, among others, to (a) interpret the Plan, (b) prescribe, amend and rescind rules and regulations relating to the Plan, and (c) make all other determinations deemed necessary or advisable for the administration of the Plan.  The Employee hereby acknowledges that a copy of the Plan has been made available to him and agrees to be bound by all the terms and provisions thereof.  The Employee and the Company each acknowledge that this Agreement (together with the Plan) constitutes the entire agreement and supersedes all other agreements and understandings, both written and oral, between the parties or either of them, with respect to the subject matter hereof.
		
	15.
	Amendment.

The Company may modify, amend or waive the terms of the CSUs and/or SSUs, prospectively or retroactively, but no such modification, amendment or waiver shall materially impair the rights of the Employee without his or her consent, except as required by applicable law, stock exchange rules, tax rules or accounting rules.  The waiver by either party of compliance with any provision of this Agreement shall not operate or be construed as a waiver of any other provision of this Agreement, or of any subsequent breach by such party of a provision of this Agreement.
		
	16.
	Section 409A.

It is the intention of the Company that the CSUs and SSUs shall either (a) not constitute “nonqualified deferred compensation” as defined under Section 409A of the Code, or (b) comply in all respects with the requirements of Section 409A of the Code and the regulations promulgated thereunder, such that no delivery of or failure to deliver Shares pursuant to this Agreement will result in the imposition of taxation or penalties as a consequence of the application of Section 409A of the Code.  CSUs and SSUs that (i) constitute “nonqualified deferred compensation” as defined under Section 409A of the Code and (ii) vest as a consequence of the Employee’s termination of employment shall not be delivered until the date that the Employee incurs a “separation from service” within the meaning of Section 409A of the Code (or, if the Employee is a “specified employee” within the meaning 

1172165
6

of Section 409A of the Code and the regulations promulgated thereunder, the date that is six months following the date of such “separation from service”).  If the Company determines after the Grant Date that an amendment to this Agreement is necessary to ensure the foregoing, it may make such an amendment, notwithstanding Section 15 above, effective as of the Grant Date or any later date, without the consent of the Employee.
		
	17.
	Headings.

The headings of Sections herein are included solely for convenience of reference and shall not affect the meaning or interpretation of any of the provisions of this Agreement.
		
	18.
	Counterparts.

This Agreement may be executed in counterparts, which together shall constitute one and the same original.
		
	19.
	Waiver and Release.

In consideration for the granting of the CSUs and SSUs, the Employee hereby waives any and all claims whether known or unknown that the Employee may have against the Company and its Subsidiaries and Affiliates and their respective directors, officers, shareholders, agents or employees arising out of, in connection with or related to the Employee’s employment, except for (1) claims under this Agreement, (2) claims that arise after the date hereof and obligations that by their terms are to be performed after the date hereof, (3) claims for compensation or benefits under any compensation or benefit plan or arrangement of the Company and its Subsidiaries and Affiliates, (4) claims for indemnification respecting acts or omissions in connection with the Employee’s service as a director, officer or employee of the Company or any of its Subsidiaries and Affiliates, (5) claims for insurance coverage under directors’ and officers’ liability insurance policies maintained by the Company or any of its Subsidiaries or Affiliates, (6) any right the Employee may have to obtain contribution in the event of the entry of judgment against the Company as a result of any act or failure to act for which both the Employee and the Company or any of its Subsidiaries or Affiliates are jointly responsible, or (7) claims under the California Fair Employment and Housing Act.  The Employee waives any and all rights under the laws of any state (expressly including but not limited to Section 1542 of the California Civil Code), which is substantially similar in wording or effect as follows:
A general release does not extend to claims that the creditor or releasing party does not know or suspect to exist in his favor at the time of executing the Release and that, if known by him or her, would have materially affected his settlement with the debtor or released party.
This waiver specifically includes all claims under the Age Discrimination in Employment Act of 1967, as amended.  The Employee acknowledges that the Employee (a) has been advised to consult an attorney in connection with entering into this Agreement; (b) has 21 days to consider this waiver and release; and (c) may revoke this waiver and release within seven days of execution upon written notice to Legal Counsel, Employment and Labor, Law Department, Unum Group, 1 Fountain Square, Chattanooga, Tennessee 37402.  The waiver and release will not become enforceable until the expiration of the seven-day period.  If the waiver and release is revoked during such seven-day period, the grant shall be void and of no further effect.
		
	20.
	Confidentiality of Schedule A to this Agreement.

By executing this Agreement, the Employee acknowledges and agrees that the provisions of Schedule A to this Agreement shall be deemed confidential information (except with respect to information that becomes generally available to the public other than as a result of disclosure by the Employee, and then only to such extent), and that the Employee will keep confidential all such provisions and shall not disclose them, directly or indirectly, to any person other than the Employee’s legal advisor as necessary in obtaining legal advice (provided that such advisor is informed of the confidential nature of such provisions and is subject to confidentiality and non-disclosure duties or obligations with respect to such provisions that are no less restrictive than those contained in this Section) or as required by law or legal process.

1172165
7

		
	21.
	Clawback.

Notwithstanding any provisions in this Agreement to the contrary, any Shares or other amounts paid or provided to the Employee pursuant to this Agreement (including any gains realized on Shares issued pursuant to this Agreement), which Shares or amounts are subject to recovery under any law, government regulation, stock exchange listing requirement, or any policy adopted by the Company from time to time, will be subject to such deductions and clawback as may be required to be made pursuant to such law, government regulation, stock exchange listing requirement, or policy as in effect from time to time.
		
	22.
	Disclosures.

Nothing in this Agreement (including Schedule A hereto) shall be construed to restrict the Employee’s ability to make a confidential disclosure of any trade secret or other confidential information, without notice to or approval by the Company, to a government official or an attorney for the sole purpose of reporting or assisting in the investigation of a suspected violation of law and the Employee shall not be held liable under this Agreement or under any federal or state trade secret law for any such disclosure.
		
	23.
	Foreign Jurisdictions.

This Agreement shall be construed, interpreted and applied in such a manner as shall be necessary to comply with any legal or regulatory requirements of any non-United States jurisdiction to which the Employee is or becomes subject.  The Company hereby delegates to each of the officers of the Company the authority for the interpretation of such matters, whose interpretations shall be final, binding and conclusive on the Employee and all individuals claiming any rights or benefits hereunder.  The following provisions shall also apply only with respect to non-U.S. employees:
(a)    The Employee shall have no rights under any employment agreement (or any alleged breach of it), whether on termination of his or her employment (whether lawfully or in breach) or otherwise, to any damages for breach of contract in respect of the loss of any benefits or any rights (including the grant or vesting of any share options or equity incentives) that he or she may have received had he or she continued to have been employed.
(b)    By executing this Agreement, the Employee also agrees to, and shall be deemed to have provided to the Company, the data protection and monitoring acknowledgement set forth in Schedule 1 attached hereto.
[Signature Page Follows]

1172165
8

IN WITNESS WHEREOF, as of the date first above written, the Company has caused this Agreement to be executed on its behalf by a duly authorized officer and the Employee has hereunto set the Employee’s hand.
	
					
	 
	Date: [Acceptance Date]
	 
	 
	EMPLOYEE: [Participant Name]

	 
	 
	 
	 
	 

	 
	 
	 
	 
	 

	 
	 
	 
	 
	[Electronic Signature]

	 
	 
	 
	 
	 

	 
	 
	 
	 
	UNUM GROUP

	 
	 
	 
	 
	 

	 
	 
	 
	By:
	 

	 
	 
	 
	 
	[Authorized Signature]

	 
	 
	 
	 
	[Name]

	 
	 
	 
	 
	[Title]

1172165
9

Schedule A
I.Performance Metrics:  Subject to the terms and conditions of the Agreement, the Employee shall be eligible to earn the designated portion of the CSUs and SSUs following the completion of each Performance Period upon satisfaction of all of the following performance metrics for the applicable Performance Period:
First Performance Period
		
	1.
	The average of the four calendar quarter-end NAIC Risk-Based Capital (RBC) Ratios during the First Performance Period must be at least 325%. 

		
	2.
	The average of the four calendar quarter-end Holding Company Cash amounts during the First Performance Period must exceed 1.0x the average of the four calendar quarter-end Fixed Costs during the First Performance Period.

		
	3.
	Achievement of an annual growth rate of 3% in Adjusted Book Value over the First Performance Period.

Second Performance Period
		
	1.
	The average of the 12 calendar quarter-end NAIC Risk-Based Capital (RBC) Ratios during the Second Performance Period must be at least 325%.

		
	2.
	The average of the 12 calendar quarter-end Holding Company Cash amounts during the Second Performance Period must exceed 1.0x the average of the 12 calendar quarter-end Fixed Costs during the Second Performance Period.

		
	3.
	Achievement of a compounded annual growth rate of 3% in Adjusted Book Value over the Second Performance Period.

Third Performance Period
		
	1.
	The average of the 20 calendar quarter-end NAIC Risk-Based Capital (RBC) Ratios during the Third Performance Period must be at least 325%.

		
	2.
	The average of the 20 calendar quarter-end Holding Company Cash amounts during the Third Performance Period must exceed 1.0x the average of the 20 calendar quarter-end Fixed Costs during the Third Performance Period.

		
	3.
	Achievement of a compounded annual growth rate of 3% in Adjusted Book Value over the Third Performance Period. 

Achievement of the first and second performance metrics set forth above for each Performance Period shall be determined after excluding the impacts of the Additional Adjustment Items.  In addition, achievement of the third performance metric set forth above for each Performance Period shall be determined after excluding the impacts of the ABV Adjustment Items.
II.Definitions:  As used herein:
“ABV Adjustment Items” means items (iii) through (viii) of the Additional Adjustment Items.
“Additional Adjustment Items” means any of the following: (i) adjustments resulting from accounting policy changes, legal or regulatory rule or law changes; (ii) the effect of any regulatory, legal or tax settlements; (iii) the 

1172165
A-1

impact of any acquisitions, divestitures or block reinsurance transactions; (iv) adjustments to the closed block of business; (v) the effect of changes to strategic asset allocation; (vi) debt issuance, repurchasing or retirement, or stock repurchase or issuance; (vii) fees or assessments, including tax assessments, from legislation enacted after the date hereof; and (viii) the effect of a global pandemic or other economic and environmental pressures negatively impacting results.
“Adjusted Book Value” means, as of any date of determination, the total stockholders’ equity of the Company and its subsidiaries, as reflected on the consolidated balance sheet of the Company and its subsidiaries at such date prepared in accordance with generally accepted accounting principles, adjusted to exclude the value of accumulated other comprehensive income or loss reflected on such consolidated balance sheet.
“Fixed Costs” means, with respect to any calendar year, the total expenditures of the Company and its intermediate holding companies for dividends to stockholders of the Company and interest payments due on outstanding indebtedness of the Company and its subsidiaries during such calendar year.
“Holding Company Cash” means, as of any date of determination, the total value of the fixed maturity securities, short-term investments, and cash held on the balance sheets of the Company and its intermediate holding companies at such date prepared in accordance with generally accepted accounting principles.
“NAIC” means the National Association of Insurance Commissioners.
“NAIC Risk-Based Capital (RBC) Ratio” means, with respect to any calendar quarter, the ratio (expressed as a percentage) calculated by dividing (i) the sum of the Total Adjusted Capital of each of the Company’s traditional U.S. life insurance subsidiaries (which for the avoidance of doubt excludes captive insurers) (the “Traditional Insurers”) as of the end of such calendar quarter, by (ii) the sum of the Company Action Level RBC of each of the Traditional Insurers as of the end of such calendar quarter. As used herein, the term “Total Adjusted Capital” and “Company Action Level RBC” shall, for each Traditional Insurer, have the meanings ascribed to them under the insurance laws and regulations of the U.S. state in which the Traditional Insurer is domiciled or, if not defined thereunder, in the NAIC’s Risk-Based Capital (RBC) for Insurers Model Act, as in effect at the end of the calendar quarter to which the calculation of the NAIC Risk-Based Capital (RBC) Ratio relates.
III.Confidentiality:  Except as provided in Section 20 or 22 of the Agreement, the provisions of this Schedule A are strictly confidential and shall not be disclosed, directly or indirectly, to any person other than the Employee’s legal advisor as necessary in obtaining legal advice (provided that such advisor is informed of the confidential nature of such information and is subject to confidentiality and non-disclosure duties or obligations with respect to such information that are no less restrictive than the provisions of Section) or as required by law or legal process.

1172165
A-2

SCHEDULE 1 (FOR NON-U.S. EMPLOYEES)
Data Protection and Monitoring Acknowledgement
To: [Name of Employer] (the “Company”)
I hereby acknowledge having been informed that the Company and Affiliates may hold and process information about me for legal, personnel, administrative and management purposes and, in particular, collecting and processing:  (a) contact information to create and maintain my employee records, grant me access to internal systems, manage an internal employee directory, and communicate with me for business purposes or emergencies; (b) national identification information to ensure my eligibility to work; (c) information about the duration of sick leave to monitor sick leave and sick pay, to administer benefits and take decisions as to my fitness to work or the need for adjustments in the workplace; (d) performance and job-related information, qualifications, and professional memberships to administer performance reviews, benefits and other awards, staff restructuring, conflict of interest reporting, as well as assess my personal and professional development; (e) disciplinary, capability, and conduct information required to carry out disciplinary and grievance procedures, internal investigations and considering reports (which may be submitted anonymously) under any whistle-blowing procedure; (f) any information relating to criminal proceedings in which I have been involved to determine my suitability for certain jobs; and (g) financial, salary, and benefits information for the payment of wages and other benefits; (h) biometric information to monitor and record my hours of work where permitted by law; and (i) beneficiaries, dependents, and emergency contact information to administer benefits and contact the designated contacts in the case of emergency (my “Personal Data”).
I understand that, notwithstanding anything to the contrary herein, Company may process my Personal Data without my consent under certain lawful bases, including when processing is necessary for the performance of a contract to which I am a party; when processing is necessary for compliance with a legal requirement; or when processing is necessary to protect vital interests.
I agree that the Company may make my Personal Data available to Affiliates, those who provide products or services to the Company and Affiliates (such as advisers and payroll administrators), regulatory authorities, potential or future employers, governmental or quasi-governmental organizations, current or potential investors and potential purchasers of the Company or the business in which I work.  I agree that the Company may use and make my Personal Data available to third parties to comply with obligations to third parties; establish or defend legal claims or allegations; and detect security incidents, protect against malicious deceptive, fraudulent, or illegal activity.
I understand that my Personal Data may be transferred to any Affiliate established outside the European Economic Area, and in particular to the United States.  I acknowledge that these countries may not have laws in place to adequately protect my privacy, but that a Data Transfer Agreement which utilized EU Model Clauses has been implemented with such Affiliates.
I understand that all communications (whether by telephone, email or any other means) which are transmitted, undertaken or received using Company property or on Company premises will be treated by the Company as work related and are subject to occasional interception, recording and monitoring without further notice.  I do not regard any such communications as private and I consent to such interception, recording and monitoring.
Interception, recording and monitoring of communications is intended to protect the Company’s business interests (for example, but without limitation, for the purposes of quality control, security of communication and IT systems, record-keeping and evidential requirements, detection and prevention of criminal activity or misconduct and to assist the Company to comply with relevant legal requirements).  I acknowledge that intercepted communications may be used as evidence in any disciplinary or legal proceedings.
I understand that I have the right to withdraw my agreement to the collection and processing of Personal Data.  If I would like to withdraw my agreement, I can contact the Privacy Office at privacy@unum.com or 1-877-684-1241.
I have read, understood and agreed to the above of my own free will.

1172165

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00313-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00313-of-00352.parquet"}]]